SMARCA4 and cancer: In a similar way in which BRM incorporation is known to compensate for BRG1 loss in BRG1-mutant cancers [91], BRG1 overexpression may reduce the number of BRM containing SWI/SNF complexes and caused preferential ATPase recruitment.